Granulocyte Colony-Stimulating Factor(G-CSF): Clinical Trials

4 trials of Granulocyte Colony-Stimulating Factor(G-CSF), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed. 4 Phase 2, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 3, Completed 1
Phase 34Unknown 3, Completed 1

Follow Granulocyte Colony-Stimulating Factor(G-CSF): new trials by email Literature Review of Granulocyte Colony-Stimulating Factor(G-CSF) trials Research Report on Granulocyte Colony-Stimulating Factor(G-CSF)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT
Granulocyte Colony-Stimulating Factor(G-CSF), Decitabine (DAC), Busulfan (BU) - Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University2322022-07-012022-07-08
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT
Granulocyte Colony-Stimulating Factor(G-CSF), Decitabine (DAC), Busulfan - Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University2422022-07-012023-03-21
G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
Granulocyte Colony-Stimulating Factor(G-CSF), Decitabine (DAC), Busulfan (BU) - Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University2422021-01-152021-01-19
G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT
Decitabine, Busulfan (BU), Cyclophosphamide (CY) - Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 / Phase 3CompletedNanfang Hospital, Southern Medical University2022016-04-182022-02-14

Conditions studied

Myelodysplastic Syndromes (3)

Sponsors

Nanfang Hospital, Southern Medical University (4)

Countries

China (4)

Top investigators

Qifa Liu (3)

Results publications

PMID 36702138